The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.

ConditionHPV Infection

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age25-65

SponsorLo.Li.Pharma s.r.l

About this trial

The purpose of the study is to test the effect of the administration of a dietary supplement consisting of epigallocatechin gallate (EGCG), vitamin B12 and folic acid in the treatment of infections with papilloma virus of the cervix.

Eligibility criteria

Qualifiers

HR-HPV DNA test positivity

Disqualifiers

No HSIL

Trial design

Treatments tested in this trial

EGCG + folic acid + B12

Treatment groups

100 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Lo.Li.Pharma s.r.l

Lead sponsor

Source ClinicalTrials.gov